ASCEND BY NTHRYS
Research Abroad Products

Pharmacogenetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
TPMT and COMT Metabolizer Status Commercial Testing Service
A direct-to-consumer and B2B genetic testing service that rapidly profiles thiopurine and catecholamine metabolism to optimize analgesic and anti-inflammatory drug selection. Revenue streams include test subscription fees ($200-400 per patient), insurance billing, and enterprise licensing to pharmacy chains and pain management clinics.
Pain Management Pharmacogenetics Analytics Click to view more details →
Predictive Pain Management Pharmacogenomics Software-as-a-Service
A machine learning-powered SaaS platform that combines genetic profiles, medication history, and comorbidity data to forecast pain medication efficacy and adverse event risk at the individual level. Generates recurring enterprise revenue through health system licensing, pharmacy network integrations, and value-based care partnerships that reward better pain control outcomes.
Pain Management Pharmacogenetics Analytics Click to view more details →
Multi-Gene Pain Medication Compatibility Checker Tool
A lightweight clinical decision support tool that cross-references patient genotypes across CYP2D6, CYP3A4, CYP2C9, and TPMT to identify safe pain medication combinations and avoid harmful drug interactions. Commercial deployment targets retail pharmacies, urgent care centers, and ambulatory pain clinics through white-label licensing at $10K-30K annually per location.
Pain Management Pharmacogenetics Analytics Click to view more details →
Precision Dosing Algorithm for Tramadol and Codeine Products
A proprietary algorithm embedded in pharmacy management systems that calculates personalized safe dosing ranges for prodrug-dependent opioids based on genetic metabolizer phenotypes and real-time drug interaction screening. Pharmaceutical manufacturers license the technology to increase product adoption and differentiate in the precision medicine market, generating $500K-2M in annual licensing fees.
Pain Management Pharmacogenetics Analytics Click to view more details →
Insurance-Integrated Pharmacogenomic Pre-Authorization Clearance Platform
A B2B workflow automation platform that integrates with payer systems to automatically flag medication requests requiring genetic testing and streamline pre-authorization based on pharmacogenomic evidence. Payers reduce claims denials by 25%, decrease administrative burden, and contract for analytics services generating $2M-5M annual revenue from large insurance networks.
Pain Management Pharmacogenetics Analytics Click to view more details →
NSAIDs and Analgesic Responder Biomarker Panel Commercial Service
A specialized genetic testing service that profiles pain medication response biomarkers including OPRM1, COMT, and inflammatory pathway variants to predict NSAID and acetaminophen efficacy. Labs and clinics generate $300-600 per test, with institutional contracts for high-volume pain centers, rheumatology practices, and orthopedic surgery centers driving $500K-1.5M annual revenue.
Pain Management Pharmacogenetics Analytics Click to view more details →
Acute Post-Operative Pain Management Genomic Risk Stratification Tool
A perioperative clinical tool that genotypes patients pre-surgery to predict opioid needs, adverse reaction risk, and optimal analgesic protocols for post-operative pain management. Surgical centers and hospitals implement through EHR integration to reduce opioid consumption by 30%, decrease PACU complications, and improve discharge timelines, justifying $25K-75K annual licensing fees.
Pain Management Pharmacogenetics Analytics Click to view more details →
Chronic Pain Patient Stratification Engine for Pharmaceutical Market Access
A commercial analytics platform that segments chronic pain populations by pharmacogenomic profiles and medication response patterns to support drug manufacturer market access and payer negotiation strategies. Pharmaceutical companies pay $1M-5M for predictive segmentation data and real-world evidence to justify premium pricing and formulary placement for new analgesic compounds.
Pain Management Pharmacogenetics Analytics Click to view more details →
Real-time Warfarin Dosing Optimization Engine
A SaaS platform that integrates CYP2C9 and VKORC1 genetic data to generate personalized warfarin dosing recommendations in clinical workflows. This reduces adverse events, hospital readmissions, and enables healthcare providers to offer premium pharmacogenetic consultation services.
Warfarin Pharmacogenetics Analytics Platform Click to view more details →
Clinical Lab Integration Middleware for Genetic Testing
A middleware tool that seamlessly connects laboratory information systems with warfarin pharmacogenetics analytics, automating result delivery to EHRs and clinical decision support systems. It creates new revenue streams through laboratory partnerships and reduces manual data entry costs by up to 80%.
Warfarin Pharmacogenetics Analytics Platform Click to view more details →
Patient Risk Stratification and Bleeding Prediction Dashboard
An analytics dashboard that combines genetic polymorphisms, drug interactions, and comorbidity data to predict bleeding risk and patient non-compliance with warfarin therapy. Healthcare systems can monetize this through risk-based pricing models and proactive intervention programs that reduce costly bleeding events.
Warfarin Pharmacogenetics Analytics Platform Click to view more details →
Multi-Gene Warfarin Interaction Database and API
A comprehensive RESTful API platform that catalogs interactions between warfarin, CYP2C9, VKORC1, and emerging genetic variants with real-time clinical evidence updates. This becomes a white-label service for EHR vendors, pharmacy chains, and telemedicine platforms seeking differentiated pharmacogenetic capabilities.
Warfarin Pharmacogenetics Analytics Platform Click to view more details →